Since we found significant reduced tumor growth with CMTM4 KD/KO cancer cells in vivo (Fig. 2A–C) but not in vitro (Appendix Fig. S4C), we determined whether the immune response, especially the adaptive immunity, is required for the retarded tumor growth. The gene discussed is CMTM4; the disease is neoplasm.